Dive into a collection of past posts and rediscover timeless content.
Sep 11, 2026
•
6 min read
Novartis's MS data, rare disease firsts, and an exciting update from Precedent Therapeutics
Sep 4, 2026
Aug 28, 2026
5 min read
Aug 21, 2026
Rare disease momentum, MS data, and the leaders building what comes next
Aug 14, 2026
3 min read
